This section reflects frequently asked questions concerning the Anthrax Vaccination Immunization Program.

AVIP Redeployment AVIP Resumption Countering the Threat The Anthrax Vaccine People Issues Production Issues Biological Warfare Issues Myths and Facts

Click here to download a PDF version of all Q&A’s

AVIP Redeployment (back to top)

Regarding Redeployment

AVIP Resumption (back to top)

Policy and Management Questions Threat Effectiveness Health and Safety Vaccine Production, Procurement and Inventory Military Discipline

Countering the Threat (back to top)

Anthrax Weapons -- The Threat Immunization Program Implementation Anthrax -- The Disease Vaccines -- General Information

The Anthrax Vaccine (back to top)

Independent Scientific Reviews of Anthrax Vaccine Anthrax Vaccine -- Overview Anthrax Vaccine -- Civilian Inquiries Anthrax Vaccine -- Eligibility Criteria Anthrax Vaccine -- Effectiveness Anthrax Vaccine -- Ingredients Anthrax Vaccine -- Safety Anthrax Vaccine -- Long-Term Safety Anthrax Vaccine -- Legal Status Vaccination & Reproductive Health Anthrax Vaccine & The Persian Gulf War Next Generation Anthrax Vaccine (NGAV)

People Issues (back to top)

Educational Materials Reserve Components Other Personnel Categories Refusal Vaccine Religious Waivers

Production Issues (back to top)

Anthrax Vaccine -- Production Issues FDA Inspections, 1969 - present The Facts on Squalene

Biological Warfare Issues (back to top)

Joint Program Office for Biological Defense (JPO-BD)

Myths and Facts (back to top)

Myths and Facts